CB Scientific, Inc. (CBSC) enters into a Consultant Services Agreement with the Dorchester Group LLC - Seite 2

CB Scientific plans to make further announcements to keep its shareholders, industry participants, and the public markets informed through press releases and regulatory filings as new developments occur.

About CB Scientific:

Revolutionary Any-Doctor-Any Where, at Home Heart Rate Monitor.

CB Scientific has perfected an innovative telehealth tool available on the market today to monitor patients' heart rhythms remotely - with the goal of potentially monitoring millions of patients worldwide.

Its FDA-approved My-Cam™ remote at-home heart monitoring device and proprietary smartphone app - works with any standard Android and iOS (Apple) cell phone and syncs with ease and near-perfect harmony.

The product is monitored via its 24/7 cloud-based MY-Cardia™ portal, to include any-Doctor-anywhere access, which can be notified immediately of significant findings.

CB Scientific Inc. - Company Contact Information: 
340 State Place
Escondido, CA 92029

Telephone Number:
[phone]

Emails:
General inquires: [e-mail]
Robert Hesse - [e-mail]

Company Website and Social Media Outlets:
Twitter, Facebook, Instagram, LinkedIn, YouTube, and Newsletter

This information disclosure may contain forward-looking statements covered within the meaning of the Private Securities Litigation Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions, and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties, including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.